Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NA-1 in SAH patients undergoing endovascular repair
NCT02056574Phase 2Withdrawn
- Sponsor
- NoNO Inc.
- Start
- Nov 2015
- Primary completion
- Nov 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of nerinetide in subarachnoid hemorrhage (SAH), intracranial aneurysm, sponsored by NoNO Inc.. Planned start Nov 2015; status: withdrawn.
02
Drugs
nerinetide
03
Conditions
subarachnoid hemorrhage (SAH)intracranial aneurysm
Beyond the preview
Go deeper on NCT02056574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056574.